Trials / Completed
CompletedNCT02920931
A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tenofovir disoproxil |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-09-30
- Last updated
- 2017-01-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02920931. Inclusion in this directory is not an endorsement.